Anti-Melanogenic Effect from Submerged Mycelial Cultures of Ganoderma weberianum

References

• D’Mello S, Finlay G, Baguley B, et al. Signaling pathways in melanogenesis. Int J Mol Sci. 2016;17:1144.
   PubMed Web of Science ®Google Scholar
• Lee CS, Park M, Han J, et al. Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation. J Invest Dermatol. 2013;133:1063–1071.
   Web of Science ®Google Scholar
• Kim K. Effect of ginseng and ginsenosides on melanogenesis and their mechanism of action. J Ginseng Res. 2015;39:1–6.
   PubMed Web of Science ®Google Scholar
• Weiner L, Fu W, Chirico WJ, et al. Skin as a living coloring book: how epithelial cells create patterns of pigmentation. Pigment Cell Melanoma Res. 2014;27:1014–1031.
   PubMed Web of Science ®Google Scholar
• Chung KW, Jeong HO, Lee EK, et al. Evaluation of antimelanogenic activity and mechanism of galangin in silico and in vivo. Biol Pharm Bull. 2018;41:73–79.
   Web of Science ®Google Scholar
• Zhang L, Ding ZY, Xu P, et al. Methyl lucidenate F isolated from the ethanol-soluble-acidic components of Ganoderma lucidum is a novel tyrosinase inhibitor. Biotechnol Bioproc E. 2011;16:457–461.
   Web of Science ®Google Scholar
• Chang TS. An updated review of tyrosinase inhibitors. Int J Mol Sci. 2009;10:2440–2475.
   PubMed Web of Science ®Google Scholar
• Lee SY, Baek N, Nam T-g. Natural, semisynthetic and synthetic tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2016;31:1–13.
   PubMed Web of Science ®Google Scholar
• Campos PM, Horinouchi CDD, Prudente AD, et al. Effect of a Garcinia gardneriana (Planchon and Triana) Zappi hydroalcoholic extract on melanogenesis in B16F10 melanoma cells. J Ethnopharmacol. 2013;148:199–204.
   PubMed Web of Science ®Google Scholar
• Pengjiao Z, Zhihua G, Xuan Z, et al. Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China. J Cell Mol Med. 2018;0:3278–3297.
   Google Scholar
• Pi CC, Chu CL, Lu CY, et al. Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo. Vaccine. 2014;32:401–408.
   PubMed Web of Science ®Google Scholar
• Hsu KD, Chen HJ, Wang CS, et al. Extract of Ganoderma formosanum mycelium as a highly potent tyrosinase inhibitor. Sci Rep. 2016;6:32854.
   Web of Science ®Google Scholar
• Chien CC, Tsai ML, Chen CC, et al. Effects on tyrosinase activity by the extracts of Ganoderma lucidum and related mushrooms. Mycopathologia. 2008;166:117–120.
   Web of Science ®Google Scholar
• Mukaiyama T, Tsujimura N, Otaka S, et al. Anti-melanogenic activity of ergosterol peroxide from Ganoderma lucidum on a mouse melanoma cell line. Animal Cell Technology: Basic & Applied Aspects. Berlin, Germany: Springer; 2008. p. 273–277.
   Google Scholar
• Kim JW, Kim HI, Kim JH, et al. Effects of ganodermanondiol, a new melanogenesis inhibitor from the medicinal mushroom Ganoderma lucidum. Int J Mol Sci. 2016;17:E1798.
   Web of Science ®Google Scholar
• Likhitwitayawuid K, Sritularak B. A new dimeric stilbene with tyrosinase inhibitiory activity from Artocarpus gomezianus. J Nat Prod. 2001;64:1457–1459.
   PubMed Web of Science ®Google Scholar
• Arung ET, Furuta S, Ishikawa H, et al. Anti-melanogenesis properties of quercetin- and its derivative-rich extract from Allium cepa. Food Chem. 2011;124:1024–1028.
   Web of Science ®Google Scholar
• Park KM, Kwon KM, Lee SH. Evaluation of the antioxidant activities and tyrosinase inhibitory property from mycelium culture extracts. Evid-Based Compl Alt. 2015;2015:1.
   Google Scholar
• Chen XX, Shi Y, Chai WM, et al. Condensed tannins from Ficus virens as tyrosinase inhibitors: structure, inhibitory activity and molecular mechanism. Plos One. 2014;9:e91809.
   Web of Science ®Google Scholar
• Chai WM, Lin MZ, Song FJ, et al. Rifampicin as a novel tyrosinase inhibitor: inhibitory activity and mechanism. Int J Biol Macromol. 2017;102:425–430.
   PubMed Web of Science ®Google Scholar
• Boonkaew B, Kempf M, Kimble R, et al. Cytotoxicity testing of silver-containing burn treatments using primary and immortal skin cells. Burns. 2014;40:1562–1569.
   Web of Science ®Google Scholar
• Geng Y, Zhu S, Lu Z, et al. Anti-inflammatory activity of mycelial extracts from medicinal mushrooms. Int J Med Mushrooms 2014;16:319–325.
   Google Scholar
• Huang HC, Hsieh WY, Niu YL, et al. Inhibitory effects of adlay extract on melanin production and cellular oxygen stress in B16F10 melanoma cells. Int J Mol Sci. 2014;15:16665.
   Web of Science ®Google Scholar
• Burnett CL, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of kojic acid as used in cosmetics. Int J Toxicol. 2010;29:244s–273s.
   PubMed Web of Science ®Google Scholar
• Takizawa T, Imai T, Onose J-i, et al. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis (2-hydroxypropyl) nitrosamine or N-diethylnitrosamine. Toxicol Sci. 2004;81:43–49.
   PubMed Web of Science ®Google Scholar
• Hsu KD, Chan YH, Chen HJ, et al. Tyrosinase-based TLC autography for anti-melanogenic drug screening. Sci Rep. 2018;8:401.
   PubMed Web of Science ®Google Scholar
• Praca FSG, Medina WSG, Eloy JO, et al. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models. Eur J Pharm Sci. 2018;111:121–132.
   PubMed Web of Science ®Google Scholar